|

MS-ResearchBiomarkerS

RECRUITINGSponsored by Cedars-Sinai Medical Center
Actively Recruiting
SponsorCedars-Sinai Medical Center
Started2021-11-11
Est. completion2041-11-11
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects who meet any one of the following diagnostic criteria:

  * Diagnosis of MS, CIS,or RIS based on the 2017 revised McDonald criteria.
  * Diagnosis of NMOSD based on the 2015 revised NMOSD consensus diagnostic criteria.
  * Diagnosis of myelin oligodendrocyte glycoprotein (MOG)-related encephalomyelitis, optic neuritis, or other associated disease.
  * Diagnosis of neurological disorders other than MSRD.
  * Healthy volunteer.
* Age ≥18.
* Able to give informed consent.

Exclusion Criteria:

* Patients will be excluded from the MRI portions of the study if they have a contraindication to MRI(metallic implantsor foreign bodies, claustrophobia, MRI-incompatible pacemakers, MRI- incompatible prosthetic heart valves).
* Patients will be excluded from the MRI portions of the study if they are pregnant, but their demographic, clinical information,and disability measures may still be captured under the study.
* Patients will be excluded from the visual assessment portions of the study if they have had any recent ocular surgery (within the past two months), refractive errors of greater than or equal to ±6 diopters or other eye diseases that may affect or confound OCT/OCTA measurements (ex., age-related macular degeneration, advanced geographic atrophy, diabetic retinopathy, glaucoma).

Conditions11

Clinically Isolated SyndromeHealthy AgingMultiple SclerosisMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseNeurologic Autoimmune DiseaseNeurologic DisorderNeuromyelitis Optica Spectrum Disorders

Locations1 site

Cedars-Sinai Medical Center
Los Angeles, California, 90048
Omar Al-Louzi, MD310-423-4008omar.allouzi@cshs.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.